A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects (NCT07219940)
An Open-label and Dose-escalation Phase I Clinical Study to Evaluate the Tolerability, Safety, and Pharmacokinetics of HLA-G-targeted Exosome (SOB100) in Healthy Subjects
🩺 Plain-English Summary (8th-Grade Level)
The investigational drug, SOB100, is an HLA-G targeted exosome equipped with a nanobody namely anti-HLA-G VHH on the exosome membrane. This is a Phase I dose escalation study to exam the tolerability, safety, and pharmacokinetics in healthy subjects.
Who can join: Review the eligibility criteria below.
Location: Parexel International - Baltimore Early Phase Clinical Unit — Baltimore, Maryland
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Parexel International - Baltimore Early Phase Clinical Unit — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: +886423272888
Email: rd005@shineon-bio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Healthy Subjects
- Metabolic Responses to Spermidine Supplementation. — Addison, Illinois
- Lysine-specific Demethylase 1 and Salt-sensitivity in Humans — Boston, Massachusetts
- Effect of Stimulation on the Vagus Nerve — Indianapolis, Indiana
- Training Effects on Fuel Metabolism — Minneapolis, Minnesota
- Methemoglobin Concentration in High Dose Inhaled Nitric Oxide — Boston, Massachusetts
- Effect of Proton Pump Inhibitors on Gut Microbiota Composition and Metabolites in Healthy Subjects Using CapScan — Mountain View, California
Explore by condition: All Healthy Subjects clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.